BackDeciphera Pharmaceuticals Overview

Deciphera Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for DCPH.

Quarterly EBIT

-$48.85M
↑ 9.32% YoY

As of Mar 31, 2024

Annual EBIT (TTM)

-$207.01M
↓ 9.13% YoY

Trailing 12 months ending Mar 31, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin